ArticleFrontiers in oncology2024

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study.

Jie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.